In contrast, overexpression of PIAS3 in the U251-MG human glioma cell line inhibited the expression of the OSM-enhanced STAT3 target genes (e.g., Survivin, Bclxl, and SOCS3), which resulted in reduction of cell proliferation by 80%. This evidence concerns the gene BIRC5 and central nervous system cancer.